Brian M Sandroff1,2, Robert W Motl3, Cristina A F Román4,5, Glenn R Wylie4,5, John DeLuca4,5, Gary R Cutter6, Ralph H B Benedict7, Michael G Dwyer7, Robert Zivadinov7. 1. Center for Neuropsychology and Neuroscience Research, Kessler Foundation, 1199 Pleasant Valley Way, West Orange, NJ, 07052, USA. bsandroff@kesslerfoundation.org. 2. Rutgers New Jersey Medical School, Newark, NJ, USA. bsandroff@kesslerfoundation.org. 3. University of Illinois Chicago, Chicago, IL, USA. 4. Center for Neuropsychology and Neuroscience Research, Kessler Foundation, 1199 Pleasant Valley Way, West Orange, NJ, 07052, USA. 5. Rutgers New Jersey Medical School, Newark, NJ, USA. 6. University of Alabama at Birmingham, Birmingham, AL, USA. 7. University at Buffalo, Buffalo, NY, USA.
Abstract
BACKGROUND AND OBJECTIVES: Thalamic atrophy (TA) represents a biomarker of neurodegeneration and associated dysfunction/decline in physical and cognitive functioning among persons with multiple sclerosis (MS). Aerobic fitness, as an end point of exercise training, represents a promising target for restoring function in MS, but it is unknown if such effects differ by TA. This cross-sectional study examined whether aerobic fitness was differentially associated with cognitive processing speed and walking endurance in persons with MS who present with and without TA. METHODS: 44 fully ambulatory persons with MS completed a graded exercise test for measuring aerobic fitness (VO2peak) and underwent 3T MRI for measuring TA, the Symbol Digit Modalities Test (SDMT), and the 6-min walk (6MW). We performed Spearman correlations (rs) among VO2peak, SDMT, and 6MW scores overall, and in persons with and without TA. We applied Fisher's z-test for comparing correlations based on TA status. RESULTS: When controlling for age, EDSS score, and global MRI measures of atrophy, VO2peak was strongly associated with SDMT scores (prs = 0.74, p < 0.01) and 6MW performance (prs = 0.77, p < 0.01) in persons with TA, whereas VO2peak was not associated with SDMT scores (prs = - 0.01, p = 0.99) or 6MW performance (prs = 0.25, p = 0.38) in those without TA. The correlations between VO2peak and SDMT (z = 2.86, p < 0.01) and VO2peak and 6MW (z = 2.33, p = 0.02) were significantly stronger in the TA group. DISCUSSION: This study provides initial evidence of strong, selective associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with TA as a biomarker for MS-related neurodegeneration. Such data support TA as a moderator of the association among aerobic fitness, cognitive processing speed, and walking endurance in persons with MS. Future research should carefully consider the role of TA when designing trials of aerobic exercise, cognition, and mobility in MS.
BACKGROUND AND OBJECTIVES: Thalamic atrophy (TA) represents a biomarker of neurodegeneration and associated dysfunction/decline in physical and cognitive functioning among persons with multiple sclerosis (MS). Aerobic fitness, as an end point of exercise training, represents a promising target for restoring function in MS, but it is unknown if such effects differ by TA. This cross-sectional study examined whether aerobic fitness was differentially associated with cognitive processing speed and walking endurance in persons with MS who present with and without TA. METHODS: 44 fully ambulatory persons with MS completed a graded exercise test for measuring aerobic fitness (VO2peak) and underwent 3T MRI for measuring TA, the Symbol Digit Modalities Test (SDMT), and the 6-min walk (6MW). We performed Spearman correlations (rs) among VO2peak, SDMT, and 6MW scores overall, and in persons with and without TA. We applied Fisher's z-test for comparing correlations based on TA status. RESULTS: When controlling for age, EDSS score, and global MRI measures of atrophy, VO2peak was strongly associated with SDMT scores (prs = 0.74, p < 0.01) and 6MW performance (prs = 0.77, p < 0.01) in persons with TA, whereas VO2peak was not associated with SDMT scores (prs = - 0.01, p = 0.99) or 6MW performance (prs = 0.25, p = 0.38) in those without TA. The correlations between VO2peak and SDMT (z = 2.86, p < 0.01) and VO2peak and 6MW (z = 2.33, p = 0.02) were significantly stronger in the TA group. DISCUSSION: This study provides initial evidence of strong, selective associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with TA as a biomarker for MS-related neurodegeneration. Such data support TA as a moderator of the association among aerobic fitness, cognitive processing speed, and walking endurance in persons with MS. Future research should carefully consider the role of TA when designing trials of aerobic exercise, cognition, and mobility in MS.
Authors: Robert Zivadinov; Dejan Jakimovski; Sirin Gandhi; Rahil Ahmed; Michael G Dwyer; Dana Horakova; Bianca Weinstock-Guttman; Ralph R H Benedict; Manuela Vaneckova; Michael Barnett; Niels Bergsland Journal: Expert Rev Neurother Date: 2016-05-13 Impact factor: 4.618
Authors: Christina J Azevedo; Steven Y Cen; Sankalpa Khadka; Shuang Liu; John Kornak; Yonggang Shi; Ling Zheng; Stephen L Hauser; Daniel Pelletier Journal: Ann Neurol Date: 2018-02-09 Impact factor: 10.422
Authors: Stefano Magon; Charidimos Tsagkas; Laura Gaetano; Raihaan Patel; Yvonne Naegelin; Michael Amann; Katrin Parmar; Athina Papadopoulou; Jens Wuerfel; Christoph Stippich; Ludwig Kappos; M Mallar Chakravarty; Till Sprenger Journal: J Neurol Date: 2020-02-10 Impact factor: 4.849
Authors: Mitchell T Wallin; William J Culpepper; Jonathan D Campbell; Lorene M Nelson; Annette Langer-Gould; Ruth Ann Marrie; Gary R Cutter; Wendy E Kaye; Laurie Wagner; Helen Tremlett; Stephen L Buka; Piyameth Dilokthornsakul; Barbara Topol; Lie H Chen; Nicholas G LaRocca Journal: Neurology Date: 2019-02-15 Impact factor: 9.910
Authors: Iris Dekker; Menno M Schoonheim; Vikram Venkatraghavan; Anand J C Eijlers; Iman Brouwer; Esther E Bron; Stefan Klein; Mike P Wattjes; Alle Meije Wink; Jeroen J G Geurts; Bernard M J Uitdehaag; Neil P Oxtoby; Daniel C Alexander; Hugo Vrenken; Joep Killestein; Frederik Barkhof; Viktor Wottschel Journal: Neuroimage Clin Date: 2020-12-24 Impact factor: 4.881
Authors: Robert W Motl; Brian M Sandroff; Ralph Hb Benedict; Elizabeth A Hubbard; Lara A Pilutti; Bradley P Sutton Journal: Mult Scler Date: 2020-03-31 Impact factor: 6.312